Congressional Record—House H5074
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Paul Offit: Claiming the High Gr Ound I N the Vaccine C Ontroversy
PaUl oFFIt: CLAIMInG tHe HIGH GR oUnD I n tHe VaCCINE C ontRoVeRsY BY B rian G. Connell Y aul aul s my my a ourtesy c hen Paul Offit (Res ’80) was a resi- dent in the emergency department at / photo WChildren’s Hospital of Pittsburgh in RRIS the late 1970s, he had a patient—a 9-month- rank ha old infant—who died of rotavirus. Offit was f shocked to realize that this common intestinal infection still killed children in the United illustration States. A leading cause of severe diarrhea in Offit is co-inventor of the rotavirus vaccine RotaTeq, which was recommended for routine infants and young children, rotavirus contrib- immunizations in infants by the World Health Organization. utes to more than half a million deaths world- wide each year. have advanced the belief that there’s a link Offit, who has testified in congressional Some three decades later, in 2009, between vaccines and autism. The suspect hearings on vaccine safety, says the conse- RotaTeq— a vaccine for rotavirus—was recom- vaccines change, but the story remains the quences of skipping vaccines are not theo- mended by the World Health Organization to same: Citing anecdotes or data taken out of retical. He points to the pertussis outbreak in protect against the deadly infection. RotaTeq context, activist groups accuse physicians and California this year, which killed 10 infants is the fruit of 25 years of labor for Offit, the pharmaceutical companies of concealing what and infected 9,000 people. “We’re past the vaccine’s coinventor who is now a renowned they believe are harmful effects associated with tipping point,” he says. -
A Risk/Reward View of Vaccines
A Risk/Reward View of Vaccines Addressing the confusion and presenting a different approach to the vaccine question as it relates to the frum community For those interested in minimizing the growing Machlokes Ver. 11/14//2019 (latest version at www.rodefshalom613.org) email [email protected] or leave a message at (414) 751-0001 with any corrections DRAFT Table of Contents Page Time to Read Introduction 4-9 5 Min. Main Presentation 10-41 15 min Critical Update as of 4/9/19 40 Appendix A - Wakefield: Defended/Exonerated 42 Appendix B - Scientists and Doctors on Vaccine Harm 43-44 Appendix C - Literature about Vaccine Harm 45-46 Appendix C1 - Vaccines and SIDS 47-48 Appendix C2 - Vaccines, Autism, and Under 5 Mortality 49 Appendix D - Ingredients in Vaccines 50 Appendix D1 - The Difference Between Vaccines and Chemical Drugs 51 Appendix D2 - Some Biologic (Vaccine) Recalls 52-54 Appendix E - What about Herd Immunity? 55-56 Appendix F - But They Can't All Be Wrong - Can They? 57 Appendix G - Is the CDC Lying? 58-59 Appendix H - How Profitable is the Vaccine Industry? 60-62 Appendix H1 - Conflicts of Interest in the Vaccine Industry 63 Appendix I - Dr. Paul Offit on Metziza B'peh and Bris Milah 64-65 Appendix J - Why Don’t Doctors See This? 66-68 Appendix K - Specialist vs General Practitioner - Who do you go to? 69 Appendix L - Rav Osher Weiss Psak - Comprehensive Review 70-79 Appendix M - Alternate Shailos for a Posek 80 Appendix N - An Open Letter to Poskim who demand vaccination 81-84 2 Table of Contents (cont) Page Time to Read Appendix O - Religious Exemption - Do you really want to give that up? 85-86 Appendix P - Ethical Argument 87-88 Appendix Q - Books - Is it responsible to Pasken without even reading one of these? 89 Appendix R - Smallpox and Polio 90-91 92 Appendix S - Flu Vaccines 93 Appendix T - Additional Resources and Interesting Articles 94 Appendix U - A critical lesson from the Ukraine 95 Follow-up Opportunities 96 3 -An important NOTICE for you- This presentation is not pro-vaccine or anti-vaccine. -
Myocarditis and Mrna Vaccines
Updated June 28, 2021 DOH 348-828 Information for Clinical Staff: Myocarditis and mRNA Vaccines This document helps clinicians understand myocarditis and its probable link to some COVID-19 vaccines. It provides talking points clinicians can use when discussing the benefits and risks of these vaccines with their patients and offers guidance on what to do if they have a patient who presents with myocarditis following vaccination. Myocarditis information What are myocarditis and pericarditis? • Myocarditis is an inflammation of the heart muscle. • Pericarditis is an inflammation of the heart muscle covering. • The body’s immune system can cause inflammation often in response to an infection. The body’s immune system can cause inflammation after other things as well. What is the connection to COVID-19 vaccination? • A CDC safety panel has determined there is a “probable association” between myocarditis and pericarditis and the mRNA COVID-19 vaccines, made by Moderna and Pfizer-BioNTech, in some vaccine recipients. • Reports of myocarditis and pericarditis after vaccination are rare. • Cases have mostly occurred in adolescents and young adults under the age of 30 years and mostly in males. • Most patients who developed myocarditis after vaccination responded well to rest and minimal treatment. Talking Points for Clinicians The risk of myocarditis is low, especially compared to the strong benefits of vaccination. • Hundreds of millions of vaccine doses have safely been given to people in the U.S. To request this document in another format, call 1-800-525-0127. Deaf or hard of hearing customers, please call 711 (Washington Relay) or email [email protected]. -
03-584V • FRED KING and MYLINDA KING, Parents of Jordan King, a Minor V. SECRETARY OF
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 03-584V (Filed: September 22, 2011) TO BE PUBLISHED1 * * * * * * * * * * * * * * * * * * * * * * * * * * * * FRED KING and MYLINDA KING, * parents of Jordan King, a minor, * Vaccine Act Interim Costs; * Fees for Omnibus Proceedings; Petitioners, * Expert Costs; Expenditures * For Original Research v. * Articles; Dr. Mark Geier. * SECRETARY OF HEALTH AND * HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * DECISION ON REMAND CONCERNING INTERIM COSTS HASTINGS, Special Master. In this case under the National Vaccine Injury Compensation Program (hereinafter “the Program”), the petitioners seek, pursuant to 42 U.S.C. § 300aa-15(e),2 an interim award for attorneys’ costs incurred in the course of the petitioners’ attempt to obtain Program compensation. On December 13, 2010, I issued a Decision Awarding Interim Costs, which was the fifth award of interim fees and/or costs issued in this case. The petitioners sought review of that Decision, and on 1 Because I have designated this document to be published, each party has 14 days within which to request redaction “of any information furnished by that party (1) that is trade secret or commercial or financial information and is privileged or confidential, or (2) that are medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b); 42 U.S.C. § 300aa-12(d)(4)(B). Otherwise, this entire document will be available to the public. 2 The applicable statutory provisions defining the Program are found at 42 U.S.C. § 300aa- 10 et seq. (2006). Hereinafter, for ease of citation, all “§” references will be to 42 U.S.C. -
Thimerosal in Vaccines—An Interim Report to Clinicians
AMERICAN ACADEMY OF PEDIATRICS Committee on Infectious Diseases and Committee on Environmental Health Thimerosal in Vaccines—An Interim Report to Clinicians ABBREVIATIONS. AAP, American Academy of Pediatrics; and for preventing bacterial contamination, particu- USPHS, US Public Health Service; FDA, Food and Drug Admin- larly in opened multidose containers. Some but not istration; IPV, inactivated polio vaccine; OPV, oral polio vaccine; all of the vaccines recommended routinely for chil- DTP, diphtheria-tetanus-pertussis (vaccine); Hib, Haemophilus in- dren in the United States contain thimerosal.1 fluenzae type b (vaccine); EPA, Environmental Protection Agency; ATSDR, Agency for Toxic Substances and Disease Registry; Thimerosal contains 49.6% mercury by weight and is HBsAg, hepatitis B surface antigen; HBIG, hepatitis B immune metabolized to ethyl mercury and thiosalicylate. globulin. Data are limited regarding potential differences in toxicity between ethyl mercury and methyl mercury. n July 7, 1999, the American Academy of Both forms of organic mercury are associated with Pediatrics (AAP) issued with the US Public neurotoxicity in high doses, and definitive data re- Health Service (USPHS) a joint statement garding the doses at which developmental effects O occur in infants are not available. When vaccines alerting clinicians and the public of concern about thimerosal, a mercury-containing preservative used containing thimerosal have been administered in the in some vaccines. That statement was disseminated recommended doses, hypersensitivity has been widely, including on the AAP members e-mail list, noted, but no other harmful effects have been report- 2 Massive overdoses from inappropriate use of and was posted on the AAP web site since July 7, ed. -
Presentation of Stanley Plotkin
Vaccine Safety by Stanley A. Plotkin Advac Alumni 2019.pptx Sept. 22, 2019 Plotkin, Pediatrics, 2019; 143 2 (Cont.) 3 Vaccine Safety Library Topics May 2019 Heather Monk Bodenstab, PharmD, Paul Offit, MD, Frank DeStefano, MD • Adjuvants Other than Aluminum in Vaccines o Squalene (MF59, AS03, AF03) o Monophosphoryl lipid A (MPL), Saponin (QS21), and Related Adjuvant Systems (AS01, AS02, AS04) o CpG • Aluminum in Vaccines • Diabetes and Vaccines o Type-1 Diabetes o Gestational Diabetes • DNA and Vaccines • Egg Allergy and Vaccines o Influenza Vaccine o Measles-Containing Vaccine o Yellow Fever Vaccine • Guillain-Barre Syndrome (GBS) and Vaccines 4 Vaccine Safety Library Topics (cont.) May 2019 Heather Monk Bodenstab, PharmD, Paul Offit, MD, Frank DeStefano, MD • Human Papillomavirus (HPV) Vaccine Safety Concerns o HPV Vaccine and Chronic Fatigue Syndrome (CFS)/Systemic Exertion Intolerance Disease (SEID) o HPV Vaccine and Multiple Sclerosis/Central Demyelinating Disease o HPV Vaccine and Postural Orthostatic Tachycardia Syndrome (POTS) o HPV Vaccine and Primary Ovarian Insufficiency o HPV Vaccine and Promiscuity o HPV Vaccine and Venous Thromboembolism (VTE) • MMR and Autism • Multiple Sclerosis/Central Demyelinating Disease and Vaccines o Hepatitis B o Flu Vaccine • Pertussis Vaccine and Neurologic Complications • Pregnancy and Vaccines o HPV Vaccine and Pregnancy o Influenza Vaccine and Pregnancy o Pertussis-containing Vaccines and Pregnancy • Sudden-infant death syndrome (SIDS) and Vaccines • Thimerosal and Autism • Too Many, Too Soon • Vaccine Ingredients o Formaldehyde o Gelatin o Polysorbate 80 • Yeast and Vaccines 5 Package Insert for MMR Risks of a Vaccine Reaction . Soreness, redness, or rash where the shot is given and rash all over the body can happen after MMR vaccine. -
COVID-19 Vaccine and CMT – Q & A
COVID-19 Vaccine and CMT – Q & A Disclaimer: Nothing shared on these pages should be construed or is intended to be used for medical diagnosis or treatment. It should not be used in place of the advice of your physician or other qualified health care provider. Should you have any emergency questions or concerns, please contact your physician or health care provider immediately. Always consult with your physician or other health care provider to gain clarification regarding any health care related questions. This content was sourced from the CDC, the CMTA Scientific Advisory Board, the MDA and the NY Times. What are the side effects of the COVID vaccine? Will they affect my CMT? The known side effects of current and likely-to-be authorized COVID-19 vaccines are similar to those of the annual influenza vaccine. These include symptoms such as: muscle soreness at the injection site, fever, tiredness, body aches and headache. It’s important to note that at this time we do not know whether or not the COVID-19 vaccine will have a different or more serious set of side effects for CMT patients. You should talk to your doctor about the possibility of more serious side effects of a COVID-19 vaccine for you. What impacts will the vaccine have on possible future gene therapy treatments or medications? Whether the vaccine will have an adverse impact on any course of treatment that you or your loved one may be taking is something that you will want to consult with your clinician about directly. Upon the FDA authorization of the Pfizer/BioNTech vaccine, the FDA did not name any contraindications pertaining to genetic therapies or other medications particularly important to the CMT community. -
Needle Tips Fall/Winter 1998-1999
Volume 8 - Number 2 NEEDLE TIPS Fall/Winter 1998-1999 & the Hepatitis B Coalition News Published by the Immunization Action Coalition for individuals and organizations concerned about vaccine-preventable diseases. Holy contraindications, Robin! That person was coughing! WHAT'S ON THE INSIDE: Why did you vaccinate him? Ask the Experts CDC’s immunization expert Dr. William Atkinson answers your questions ......................... 1 CDC’s hepatitis experts, Harold Margolis, MD, and Linda Moyer, RN, answer hepatitis A and B questions .................................................................................................. 17 What’s New? Vaccinate, don’t vacillate! by Walter A. Orenstein, MD, Centers for Disease Control ........... 3 Vaccine highlights: new vaccines and new recommendations .............................................. 4 ? ? ? It’s federal law! by Neal Halsey, MD, Institute for Vaccine Safety ....................................... 6 What’s your state doing? hepatitis B laws, pneumococcal, influenza rates, etc. .................... 9 Unprotected people...five varicella-related deaths ................................................................ 13 Photocopy these materials! Holy missed opportunities, Batman! Polio Vaccine Information Statement (VIS) ......................................................................... 7 A mild illness is NOT a reason to NEW! Vaccinations for adults with hepatitis C virus infection ............................................. 10 withhold vaccinations. You’d know this, Revised! -
Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases
The new england journal of medicine special article Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases Saad B. Omer, M.B., B.S., Ph.D., M.P.H., Daniel A. Salmon, Ph.D., M.P.H., Walter A. Orenstein, M.D., M. Patricia deHart, Sc.D., and Neal Halsey, M.D. Abstract Vaccines are among the most effective prevention tools available to clinicians. How- From the Hubert Department of Global ever, the success of an immunization program depends on high rates of acceptance Health, Rollins School of Public Health (S.B.O.), and the Emory Vaccine Center and coverage. There is evidence of an increase in vaccine refusal in the United States (S.B.O., W.A.O.), Emory University, At- and of geographic clustering of refusals that results in outbreaks. Children with lanta; the Department of International exemptions from school immunization requirements (a measure of vaccine refusal) Health (S.B.O., D.A.S., N.H.) and the In- stitute for Vaccine Safety (N.H.), Johns are at increased risk for measles and pertussis and can infect others who are too Hopkins Bloomberg School of Public young to be vaccinated, cannot be vaccinated for medical reasons, or were vacci- Health, Baltimore; the National Vaccine nated but did not have a sufficient immunologic response. Clinicians can play a Program Office, Department of Health and Human Services, Washington, DC crucial role in parental decision making. Health care providers are cited as the most (D.A.S.); and Maternal and Child Health frequent source of immunization information by parents, including parents of un- Assessment, Washington State Depart- vaccinated children. -
IN the UNITED STATES COURT of FEDERAL CLAIMS OFFICE of SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 to Be Published
IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 To Be Published * * * * * * * * * * * * * * * * * * * * * * * * * * * * COLTEN SNYDER, by and through * KATHRYN SNYDER and JOSEPH SNYDER, * his natural guardians and next friends * Omnibus Autism * Proceeding; * Autism Spectrum Disorder, * Pervasive Developmental * Disorder, Causation, Petitioners, * Measles, MMR, Mercury, * Thimerosal, Waiver v. * Applying Daubert, * Weight of Expert Opinions, SECRETARY OF THE DEPARTMENT * Credibility of Witnesses OF HEALTH AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Christopher W. Wickersham, Sr., Esq., Lloyd Bowers, Esq., and Thomas B. Powers, Esq., for petitioners. Alexis S. Babcock, Esq., Katherine Esposito, Esq., Voris Johnson, Esq., and Vincent Matanoski, Esq., U.S. Department of Justice, Washington, DC, for respondent. DECISION1 Vowell, Special Master: On March 22, 2001, Kathryn and Joseph Snyder [“petitioners”] filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. 1 Vaccine Rule 18(b) provides the parties 14 days to request redaction of any material “(i) which is trade secret or commercial or financial information which is privileged and confidential, or (ii) which are medical files and similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” 42 U.S.C. § 300aa12(d)(4)(B). Petitioners have waived their right to request such redaction. See Petitioners’ Notice to W aive the 14-Day “W aiting” Period as Defined in Vaccine Rule 18(b), filed December 2, 2008. Respondent also waived the right to object to the disclosure of information submitted by respondent. See Respondent’s Consent to Disclosure, filed January 14, 2009. Accordingly, this decision will be publicly available immediately after it is filed. -
Print Who's Afraid of Gardasil?
Who's Afraid of Gardasil? by KAREN HOUPPERT March 8, 2007 This article appeared in the March 26, 2007 edition of The Nation. The HPV vaccine story has gotten all tangled up. As recently as June 8, 2006, public health advocates, progressives and many parents were celebrating a huge victory: The Food and Drug Administration had approved Merck's new vaccine Gardasil, a shot series that would help protect girls from cervical cancer and genital warts. To their continuing delight, the Centers for Disease Control's immunization committee recommended less than a month later that the shots immediately be given to all females between the ages of 9 and 26. The committee acted on persuasive data indicating that the vaccine, which prevents the sexually transmitted human papillomavirus (HPV), works best before girls are sexually active. Human papillomavirus is the most common sexually transmitted infection in the world, and most women have had it-- 80 percent of US women, by the CDC's estimates. Often it goes away on its own, without its carrier's awareness. But each year hundreds of thousands of women and girls in the United States develop persistent infections from it, more than 10,000 get cervical cancer and 3,700 die from the cancer. Gardasil, given in a series of three shots, protects against four strains of HPV. Two of those strains cause 70 percent of the nation's cervical cancer cases, and two of them cause 90 percent of genital warts. This new vaccine, widely given, has the potential to make cervical cancer almost obsolete here. -
Anti-Vaccine Activists, Web 2.0, and the Postmodern Paradigm –Anoverview Of
Vaccine 30 (2012) 3778–3789 Contents lists available at SciVerse ScienceDirect Vaccine j ournal homepage: www.elsevier.com/locate/vaccine Anti-vaccine activists, Web 2.0, and the postmodern paradigm –Anoverview of tactics and tropes used online by the anti-vaccination movement ∗ Anna Kata McMaster University, Psychiatry and Behavioural Neurosciences, 555 Sanatorium Road Hamilton, Ontario, Canada L9C 1C4 a r t i c l e i n f o a b s t r a c t Article history: Websites opposing vaccination are prevalent on the Internet. Web 2.0, defined by interaction and user- Received 26 May 2011 generated content, has become ubiquitous. Furthermore, a new postmodern paradigm of healthcare has Received in revised form emerged, where power has shifted from doctors to patients, the legitimacy of science is questioned, and 25 September 2011 expertise is redefined. Together this has created an environment where anti-vaccine activists are able to Accepted 30 November 2011 effectively spread their messages. Evidence shows that individuals turn to the Internet for vaccination Available online 13 December 2011 advice, and suggests such sources can impact vaccination decisions – therefore it is likely that anti- vaccine websites can influence whether people vaccinate themselves or their children. This overview Keywords: Anti-vaccination examines the types of rhetoric individuals may encounter online in order to better understand why the anti-vaccination movement can be convincing, despite lacking scientific support for their claims. Tactics Health communication Internet and tropes commonly used to argue against vaccination are described. This includes actions such as skew- Postmodernism ing science, shifting hypotheses, censoring dissent, and attacking critics; also discussed are frequently Vaccines made claims such as not being “anti-vaccine” but “pro-safe vaccines”, that vaccines are toxic or unnatural, Web 2.0 and more.